Ki Health Partners
Enabling Clinical Research Success for Small Pharma

Small and micro pharmaceutical companies are stepping up with exciting projects, creating a transformative wave in healthcare and the life sciences industry. To make a difference in alleviating patient suffering through innovative therapeutics and effectively managing their research workload, they must partner with resourceful contract research organizations (CROs). Yet, not all proficient CROs offer the responsiveness or affordability necessary for these smaller firms.

Ki Health Partners, a leading CRO, caters specifically to the requirements of small pharma and biotech firms, ensuring they feel listened to and supported every step of the way. Having transitioned from private practice research sites, academic institutions and pharmaceutical companies, its team collectively offers a wealth of experience and expertise, crucial in effectively identifying and resolving client pain points.

Believing that the ‘ki’ (key) to success is focusing on the client, Ki Health oversees every aspect of a clinical study from inception to completion. It also functions as a site management organization (SMO) maintaining its large pool of clinical trial sites.

“We are responsive to the testing requirements of smaller pharma companies, offering them a personalized, hands-on experience tailored to their needs,” says Peter McAllister, co-founder and medical director of Ki Health Partners.

Working hand-in-hand with clients, Ki Health ensures the success of the trials of their therapeutic products by providing best-in-class services in a timely, ethical and cost-effective manner. Each client is assigned a clinical research associate (CRA) and is free to personally reach out to the CEO or CMO via email or telephone. Its senior leadership is directly involved in day-to-day management and client interactions.

The company’s small size and compact structure allow for a range of relationships devoid of unnecessary bureaucratic layers while keeping its team’s expertise intact.

Its pool of professionals includes statisticians, writers, CRAs, national directors and other specialists from diverse backgrounds averaging 25 years of experience.

This experience proved invaluable in guiding a Chicago-based pain device company in choosing the appropriate clinical site for their trial. Despite reaching out to several prominent CROs, this company received little to no response or was presented with an exorbitant budget and non-satisfactory plans. Feeling overlooked and undervalued, they approached Ki Health for assistance.

It recognized that the larger CROs’ choice of sites didn’t align with the unique requirements of the pain device. In response the Ki Health team proposed the inclusion of military sites, knowing the military’s interest in innovative solutions to avoid sedative pain medications for soldiers. The trial—conducted on approximately 40 traditional research sites, along with four military sites—progressed swiftly, surpassing expectations and finishing ahead of schedule.

We are responsive to the testing requirements of smaller pharma companies, offering them a personalized, hands-on experience tailored to their needs

Unlike traditional CROs that must individually assess and vet numerous sites for each trial, Ki Health has a pre-established pool of sites. Being an SMO, it has access to approximately 30 sites across the country that have been thoroughly vetted, with known patient demographics and capabilities. This makes the choice for holding the trials easier and enrollment swifter for each client.

Apart from being a CRO and an SMO, the company offers consulting services. It includes providing guidance on transitioning medical practices to non-insurance-based business models, establishing and managing clinical trial sites, conducting research protocol feasibility assessments and designing trial studies.

Leveraging its extensive expertise and specially curated hands-on approach, Ki Health Partners provides a reassuring presence for small and micro pharma, biotech and medical device firms. Empowering its clients to shed the notion of being insignificant for industry recognition, the firm becomes a true partner dedicated to helping passionate clients explore novel and effective therapeutic solutions.